Skip to main content
  • Login
  • Contact
  • Subscriptions

Search form

Home

Deer Park Tribune

Deer Park weather

  • Home
  • News
  • Sports
  • Obituaries
  • Entertainment
    • Special Sections
    • Talking About...
  • Photos
  • Videos
  • Classifieds
    • Classified Display Ads
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Regeneron Pharmaceuticals (NQ: REGN )

492.45 USD -6.39 (-1.28%)
Official Closing Price Updated: 7:59 PM EST, Dec 4, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 961,200
Open 497.01
Bid (Size) 493.60 (5)
Ask (Size) 495.00 (7)
Prev. Close 498.84
Today's Range 490.06 - 501.85
52wk Range 328.12 - 664.64
Shares Outstanding 105,949,824
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Scott+Scott Attorneys at Law LLP Continues Investigation of Regeneron Pharmaceuticals, Inc.’s Directors and Officers for Breach of Fiduciary Duty – REGN
December 02, 2020
Scott+Scott Continues Investigation of Regeneron Pharmaceuticals, Inc.’s Directors and Officers for Breach of Fiduciary Duty – REGN 
From Business Wire News Releases
Regeneron Announces Investor Webcast at American Society of Hematology 2020 Annual Meeting
November 30, 2020
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will host a webcast on Monday, December 7, 2020 at 4:30pm EST. Management will discuss data presented at the American Society of Hematology (ASH) 2020... 
From PR Newswire

Performance

YTD
+31.90%
+31.90%
1 Month
-16.13%
-16.13%
3 Month
-15.15%
-15.15%
6 Month
-17.51%
-17.51%
1 Year
+33.69%
+33.69%

More News

Read More
Dupixent® (dupilumab) approved by European Commission as first and only biologic medicine for children aged 6 to 11 years with severe atopic dermatitis
November 30, 2020
From GlobeNewswire News Releases
Dupixent® (dupilumab) Approved by European Commission as First and Only Biologic Medicine for Children Aged 6 to 11 Years with Severe Atopic Dermatitis
November 30, 2020
From PR Newswire
Are These The Best Stocks To Watch Tomorrow? 3 Names To Watch
November 29, 2020
From Stockmarket.com
Looking For Cheap Stocks To Buy On Black Friday? 3 To Watch Before The Economic Rebound
November 27, 2020
From Stockmarket.com
3 Best ETF Picks: Megatrends To Invest In Now
December 04, 2020
From Investor's Business Daily
Is The FDA Still Approving Drugs During the Pandemic?
December 04, 2020
Tags REGN LLY Market News
From Motley Fool
Should You Sell Your Moderna Stock Now?
December 04, 2020
Tags REGN MRK Market News
From Motley Fool
A Return To A More Normal World
December 03, 2020
Tags Stocks / Equities Pharma/Biotech Healthcare
From Blogs - TalkMarkets
Notable Tuesday Option Activity: UPS, REGN, INTC
December 01, 2020
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2020 The Deer Park Tribune | 104 N. Main Street | Deer Park, WA 99006 | (509) 276-5043
All property rights for the entire contents of this publication shall be the property of The Deer Park Tribune.
No part hereof may be reproduced without prior written consent.
Privacy and Terms of Use


Site Design, Programming & Development by Surf New Media